A PHASE II TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Sym, S. J. [1 ]
Hong, J. [1 ]
Jung, M. [1 ]
Park, J. [1 ]
Cho, E. K. [1 ]
Lee, J. H. [1 ]
Lee, W. -S. [2 ]
Baek, J. -H. [2 ]
Shin, D. B. [1 ]
机构：
[1] Gachon Univ, Gil Hosp, Div Hematol & Oncol, Dept Internal Med, Inchon, South Korea
[2] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [31] Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
    Mavroudis, D
    Malamos, N
    Alexopoulos, A
    Kourousis, C
    Agelaki, S
    Sarra, E
    Potamianou, A
    Kosmas, C
    Rigatos, G
    Giannakakis, T
    Kalbakis, K
    Apostolaki, F
    Vlachonicolis, J
    Kakolyris, S
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 211 - 215
  • [32] Combination therapy of gemcitabine and S-1 in patients with metastatic pancreatic cancer
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Sudou, Kentarou
    Hara, Tarou
    Denda, Tadamichi
    Ishihara, Takeshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A89 - A89
  • [33] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
  • [34] High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients
    Vici, P
    Capomolla, E
    Foggi, P
    Carpano, S
    Conti, F
    Paoletti, G
    Cauchi, C
    Giacinti, L
    Leonetti, C
    Giannarelli, D
    Lopez, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2006, 25 (01): : 39 - 44
  • [35] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Ryunosuke Hakuta
    Tomotaka Saito
    Rie Uchino
    Takahiro Kishikawa
    Tsuyoshi Hamada
    Suguru Mizuno
    Takashi Sasaki
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2019, 37 : 338 - 344
  • [36] Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer
    Hatanaka, K.
    Komatsu, Y.
    Yuki, S.
    Nakamura, M.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 336 - 336
  • [37] A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer
    Sun Young Kim
    Yong Sang Hong
    Byung Chang Kim
    Ji Won Park
    Hyo Seong Choi
    Seung-Yong Jeong
    Dae Yong Kim
    Chang Won Hong
    Dae Kyung Sohn
    Kyung Hae Jung
    Investigational New Drugs, 2009, 27 : 269 - 274
  • [38] A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer
    Kim, Sun Young
    Hong, Yong Sang
    Kim, Byung Chang
    Park, Ji Won
    Choi, Hyo Seong
    Jeong, Seung-Yong
    Kim, Dae Yong
    Hong, Chang Won
    Sohn, Dae Kyung
    Jung, Kyung Hae
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (03) : 269 - 274
  • [39] Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
    Zang, D. Y.
    Lee, B. H.
    Park, H. -C.
    Song, H. H.
    Kim, H. J.
    Jung, J. Y.
    Kim, J. H.
    Kim, H. Y.
    Kwon, J. H.
    Hwang, S. W.
    Park, S. R.
    Park, C. H.
    Kim, K. O.
    Kim, M. -J.
    Jang, K. M.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 892 - 896
  • [40] PHASE II TRIAL OF COMBINED CHEMOTHERAPY WITH IRINOTECAN, S-1, AND BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Komatsu, Y.
    Yuki, S.
    Sogabe, S.
    Nakamura, M.
    Hatanaka, K.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 197 - 197
12345